Back to top

About Us

MIWG was formed in 2006 to seek clarity in the FDA regulatory scheme regarding the dissemination of truthful non-misleading information about prescription drugs, biological products and medical devices, and to improve the federal regulatory framework and enforcement climate affecting manufacturer dissemination of information regarding those products (including products in development and new uses of marketed products).

Members of the Medical Information Working Group:

  • Amgen Inc.
  • Bayer Healthcare Pharmaceuticals, Inc.
  • Boehringer Ingelheim Pharms., Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline, LLC
  • Johnson & Johnson
  • Novartis Pharmaceuticals Corp.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.